Dominic Smethurst's most recent trade in Corbus Pharmaceuticals Holdings Inc was a trade of 6,393 Common Stock, par value $0.0001 per share done at an average price of $6.8 . Disclosure was reported to the exchange on March 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Hol... | Dominic Smethurst | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.78 per share. | 06 Mar 2025 | 6,393 | 70,807 (0%) | 0% | 6.8 | 43,330 | Common Stock, par value $0.0001 per share |
Corbus Pharmaceuticals Hol... | Dominic Smethurst | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 91,200 | 91,200 | - | - | Stock options (right to buy) | |
Corbus Pharmaceuticals Hol... | Dominic Smethurst | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 27,200 | 77,200 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share |